153 Therapeutics

3i Partners Fund II LLC

82VS

9vc

AAA Family Office

Ab Studio

AbbVie

AbbVie Ventures

ABILITY Neurotech

ABLi Therapeutics

Accequa

Accuitis

Acelot

Actinogen Medical Ltd.

AcuraStem

Acurex Biosciences Corp.

Aditum Bio

adMare BioInnovations

Advantary Capital Partners

Aerska

Age1 Capital Management

AlbionVC

Alignment Ventures

Alithia Life Sciences Pty Ltd

Alix Ventures

Allele Capital Partners

Alleo Labs

Alloy Therapeutics

ALSA Ventures

Alto Neuroscience Inc.

Alzheimer's Drug Discovery Foundation

Andera Partners SA

ANeuroTech BV

Angelini Pharma

Angelini Ventures S.p.A.

Angels + Life.Sci Investors Network NJAngels.net

Aprecia Pharmaceuticals

Aprecia Pharmaceuticals LLC

Aqua Partners LLC

Aquillius Ventures

Arc Therapeutics

Argobio Studio

Ariadne Bio

Arvakor AB

Aspen Neuroscience

Astia Angels

AtaiBeckley

ATEM Capital

Atlas Venture GmbH

Awen GmbH

Axoltis Pharma

Bayshore Global Management

Beacon Biosignals

BERNINA BioInvest Ltd.

Bio Med Gene Ventures

BioCentury Inc.

Biogen

BioGeneration Ventures

Biomia

Bioscience Equity Partners

BIOSTART Consulting GmbH

Biotechgate

Bloom Science

Blue Matter Consulting

Bluezone Capital

Boehringer Ingelheim International GmbH

Boehringer Ingelheim Venture Fund USA

BOHE Angel Fund

BradleyWoods&Co. Ltd

Braingels

BrainScope Company Inc.

Brenig Therapeutics

Breslin AG

Brookline Capital Markets

BTIG

C.H. Boehringer Sohn AG & Co. KG

Caladrix Australia Pty Ltd

Camino Pharma LLC

Canaccord Genuity LLC

Cantor Fitzgerald

CarMa Seed Investments

Catalent

CBT Advisors

Chaanakya Capital

Cilcare

CITICS CLSA Capital Partners HK Ltd

Claris Ventures SGR SpA

ClavystBio

Click Therapeutics

CMS Medical Venture Investment Ltd.

Cognition Therapeutics

Cognitive Research Corporation

Cohesion Bureau

Compass Pathways

Convergence Partners

Cornell University

Corundum Neuroscience

Coya Therapeutics

CTI LSF

Cukierman & Co. Life Sciences

Cytora Stem

Damona Pharmaceuticals

Davos Alzheimer’s Collaborative

DB Capital

DCVC Bio

DeBere Capital Partners

Delix Therapeutics

Dementia Discovery Fund

Denovo Neuroscience

Diadem Biotherapeutics

Dolby Family Ventures

Edison Group

Eight Bridges

Eight Roads Ventures

Eisai Innovation Inc.

Eli Lilly and Company

Elmstead Partners LLC

Emory Drug Development Fund

Endeavor Venture Fund

Enveric BioSciences

EQT Life Sciences

ESC Advisors

EvoDenovo

Evox Therapeutics

F. Hoffmann-La Roche AG

F. Hoffmann-La Roche Ltd.

Fenix Group International

Ferghana Partners

FieldLine Medical

Find Therapeutics

Fontaine Capital

Fortlane Partners Corporate Finance GmbH

Frazier Life Sciences

FreeMind Group

Gain Therapeutics

Galimedix Therapeutics

Geneer Partners

Generation Capital LLC

Generation Fund Life Sciences Fund I

Gismo Therapeutics Inc.

Global Alzheimer's Platform Foundation

Global Asset Capital

Gron Ventures

GSK

H. Lundbeck A/S

H.C. Wainwright & Co.

Hanne Capital

HBM Partners AG

Health Innovation Capital

Hevolution

HMNC Brain Health

Hunniwell Lake Ventures

IAG Capital Partners

Iaso Ventures

Indaco Venture Partners SGR S.p.A.

Intermediate Capital Group PLC

Intsel Chimos

IPF Partners

Ipsos Healthcare Advisory Service

J.P. Morgan

JLS Fund II LP

Johnson & Johnson Innovation – JJDC

Johnston Associates

Junson Capital

Kaleida Capital

KdT Ventures

KeifeRx LLC

Kenai Therapeutics

Kerna Ventures

Kicker Ventures

Kinoxis Therapeutics Pty Ltd

Kynexis Therapeutics

Ladenburg Thalmann & Co. Inc.

Lifespan Vision Ventures LLC

Lilly Asia Ventures

Lionheart Ventures

LMU Munich

Lumanity

Lumina Life Sciences

Lumira Ventures

Lundbeckfonden BioCapital

Luson Bioventures

Lynx Financial

M Ventures

MAC Clinical Research

Magnet Ventures

MAPREG

Marigold Investment Management

Mass General Brigham Ventures

MC Services

Medicines Discovery Ventures

MedilaboRFP

MedinCell S.A.

MedTech Strategist

Merck KGaA

Merck Research Venture Fund

Merrill Lynch

Merz Therapeutics GmbH

Mianus Capital LLC

MindBio Therapeutics

Minoryx Therapeutics S.L.

Mizuho Securities Co.

Momentum Biotech

Mosaica Medicines

MP Healthcare Venture Management

Murck-Neuroscience LLC

Nanocarry Therapeutics

Negev Capital

Neuro-Innovators

NEUROBILT Partners

neurocare group AG

neuroClues

NeuroDex

Neurotech Reports

Neurvati Neurosciences

Neuvasq Biotechnologies SA

New Harbor Venture Partners

New Science Fund

Nexus Neurotech Ventures

NFX

NI Research Inc.

NINDS

Noble Capital Markets

Noble Equity Fund

Novartis Pharma AG

November International

Novo Holdings US Inc.

NRx Pharmaceuticals

NSIP LLC

Nucleus Network

o2h Ventures Ltd.

Observa Capital

OCA Ventures

Ontario Brain Institute

Ontario Teachers' Pension Plan

Oppenheimer & Co. Inc.

OrbiMed

Oryzon Genomics

Otsuka Pharmaceutical Co.

Oxford Science Enterprises

Paladin Capital Management LLC

Palo Alto Investors

Palo Santo Fund

Panacea Venture

Panakès Partners SGR SpA

Pangea Botanica Ltd

Particular Ventures

Penceive Technologies Corp

Pharmaphorum Media Limited

PJT Partners

Plaisance Capital Management

Playground Global

PMK-Ventures Pte. Ltd.

Porton Pharma Solutions

Precision NeuroMed

Prevail Partners LLC

Pritzker Neuropsychiatric Disorders Research Consortium

ProNeurogen

Propel Bio Partners

Prosperity7 Ventures | Aramco

Psilera Inc.

PsyMed Ventures

Pullan Consulting

Quan Capital

Qynapse

Raya Therapeutic

Receptive Bio

Reconnect Labs AG

Relentless Venture Fund

Remiges Ventures

Reunion Neuroscience

Revalesio Corp

Reviva Pharmaceuticals

RoX Health GmbH

Saniona AB

Satori Neuro Partners LP

Senovia Biosciences

SEQENS

Serenatis Bio

Shanda Grab Ventures Limited

Sherpa Healthcare Partners

Shionogi & Co.

Sifr Capital

Silicon Valley Venture Growth Partners

Sinaptica Therapeutics

Sixty Degree Capital

Sofinnova Investments

Specific Biologics Inc.

Springboard Health Angels

STALICLA SA

Stanford University

Star Tree Ventures Ltd.

SternAegis Ventures

Stifel

Stream Biomedical

SV Health Investors

Switch Therapeutics

Syndeio Biosciences

Synendos Therapeutics AG

Tailwinds Ventures

Teitur Trophics ApS

Tessara Therapeutics Pty Ltd.

The Benchmark Company

The Broad Institute

The Fulford Group Ltd.

The Global Emerging Markets Group

The Michael J. Fox Foundation for Parkinson's Research

The Venture Collective

Tiberend Strategic Advisors

Tiziana Life Sciences

Tonix Pharmaceuticals Holding Corp.

Torrey Pines Investment

Transneural Therapeutics

TransPacific Venture Capital Partners

Treo Ventures

Treventis Corporation

TRIMTECH Therapeutics

Two Bear Capital

Two Sigma Ventures

UCB Pharma

University of the Sunshine Coast

V-Bio Ventures

Vandria SA

VersaPeutics

Vickers Venture Partners

Vincere Biosciences Inc.

Vogel BioC

WBB Securities

Wellington Management

Wellington Partners

WRF Capital

XEIA Venture Partners

XellSmart Biomedical Co.

Zinc VC